Overview
Ryusuke Suzuki practices practicing medicine in Sapporo, Japan.
Their clinical expertise encompasses Liver Cancer, Lung Cancer, Lung Adenocarcinoma, and Nasopharyngeal Carcinoma.
They are actively involved in clinical research, co-authoring 42 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryusuke Suzuki
Is Ryusuke Suzuki a top-rated expert for Liver Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Ryusuke Suzuki is classified as an Experienced expert for Liver Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryusuke Suzuki participate in research or clinical trials?
Yes. Ryusuke Suzuki has published 42 articles and abstracts on conditions like Liver Cancer. You can view a list of Ryusuke Suzuki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Liver CancerSuzuki isExperienced. Learn about Liver Cancer.
- Lung AdenocarcinomaSuzuki isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerSuzuki isExperienced. Learn about Lung Cancer.
- Nasopharyngeal CarcinomaSuzuki isExperienced. Learn about Nasopharyngeal Carcinoma.
- Non-Small Cell Lung Cancer (NSCLC)